Articles published by Benzinga
Orange To Delist From NYSE To Reduce Financial Burdens
September 25, 2024
Via Benzinga
Topics
Regulatory Compliance
Windtree Therapeutics Heart Failure Drug Candidate Improves Systolic Blood Pressure
September 25, 2024
Via Benzinga
Tickers
WINT
Assessing Corsair Gaming: Insights From 6 Financial Analysts
September 25, 2024
Via Benzinga
Tickers
CRSR
A Glimpse Into The Expert Outlook On Old Second Bancorp Through 4 Analysts
September 25, 2024
Via Benzinga
Tickers
OSBC
DoorDash Stock Is Moving Higher Wednesday: What's Going On?
September 25, 2024
Via Benzinga
Tickers
DASH
HP Strengthens Digital Ecosystem Control With Vyopta Acquisition
September 25, 2024
Via Benzinga
Via Benzinga
Eli Lilly Touts Results Of EU-Approved Dermatitis Treatment, Shows Sustained Disease Control For Up To Three Years
September 25, 2024
Via Benzinga
Exposures
Product Safety
A Glimpse Into The Expert Outlook On Cleanspark Through 9 Analysts
September 25, 2024
Via Benzinga
Tickers
CLSK
Assessing Alpine Income Prop Trust: Insights From 6 Financial Analysts
September 25, 2024
Via Benzinga
Tickers
PINE
Micron Earnings Showdown: Charts Show Bulls And Bears In Standoff
September 25, 2024
Via Benzinga
Tickers
MU
Dogecoin Up 9% On The Week, Teases A 'Bullish Breakout:' Here's What The Numbers Say
September 25, 2024
Via Benzinga
Bill Gates Uses ChatGPT Daily: Microsoft Founder Shares What He Loves Most About AI Chatbot
September 25, 2024
Via Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Mortgage Demand Soars As Fed Interest Rate Cut Fuels Housing Market Revival: 'Next Spring Could See A Real Rebound'
September 25, 2024
Via Benzinga
Topics
Economy
Exposures
Interest Rates
Palantir And APA Amp Up AI Alliance: Multi-Million Dollar Deal To Transform Oil & Gas Operations
September 25, 2024
Via Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
What's Going On With Starbucks Shares Premarket Wednesday?
September 25, 2024
Via Benzinga
Merck's Experimental Favezelimab/Keytruda Combo Fails In Late-Stage Colorectal Cancer Study
September 25, 2024
Via Benzinga
Tickers
MRK
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.